Literature DB >> 9103386

Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.

M Uchiyama1, T Iwasaka, N Matsuo, T Hachisuga, M Mori, H Sugimori.   

Abstract

In the pathogenesis of cervical squamous cell carcinoma, an inverse correlation between human papillomavirus (HPV) infection and mutation of the p53 anti-oncogene has been suggested. Much less is known of a possible correlation in the case of adenocarcinoma of cervix. Twenty-five cervical adenocarcinomas and 7 adenosquamous carcinomas were analyzed for presence of HPV DNA sequences and overexpression of the p53 gene. Polymerase chain reaction revealed that 11 were positive for HPV DNA (34%). Seven were positive for HPV 16 and 5 for HPV 18. A mixed infection with HPV 16 and 18 was observed in 1 case. Patients with HPV-positive carcinoma were significantly younger than those with HPV-negative carcinoma (43 +/- 13.3 years versus 57 +/- 17.4 years, P = 0.01). Immunohistochemical staining showed that p53 was overexpressed in 11 of 32 cases (34%). Overexpression of the p53 gene was found in only 1 of 11 HPV-positive cases (9%) yet was evident in 10 of 21 HPV-negative cases (48%). This inverse association was statistically significant (P < 0.05). Prognostic analysis revealed that HPV-negative adenocarcinomas had a poorer prognosis than HPV-positive cases (P < 0.01) and that tumors with p53 overexpression also had a poorer prognosis than those without such overexpression (P < 0.01). Our observations suggest that HPV-negative or p53-positive adenocarcinomas may be a biologically distinct subset with a poorer prognosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103386     DOI: 10.1006/gyno.1997.4613

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

1.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  p53 immunohistochemical expression of Egyptian cervical carcinoma.

Authors:  H Abd El All; A Rye; P Duvillard
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

3.  Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype.

Authors:  Yasuki Kusanagi; Atsumi Kojima; Yoshiki Mikami; Takako Kiyokawa; Tamotsu Sudo; Satoshi Yamaguchi; Ryuichiro Nishimura
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

Review 4.  The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer.

Authors:  Yi Liu; Hejing Liu; Bo Sheng; Shuya Pan; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Apoptosis       Date:  2022-08-18       Impact factor: 5.561

5.  Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma.

Authors:  Tomomi Yoshida; Takaaki Sano; Tetsunari Oyama; Tatsuya Kanuma; Toshio Fukuda
Journal:  Virchows Arch       Date:  2009-09       Impact factor: 4.064

6.  Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology.

Authors:  Joo-Young Kim; Byung Ho Nam; Jin-Ah Lee
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

7.  Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.

Authors:  Y L Zhai; T Nikaido; T Toki; A Shiozawa; A Orii; S Fujii
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

8.  Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva.

Authors:  Anthony Mwololo; Joshua Nyagol; Emily Rogena; Willis Ochuk; Mary Kimani; Noel Onyango; Lorenzo Pacenti; Rosa Santopietro; Lorenzo Leoncini; Walter Mwanda
Journal:  Infect Agent Cancer       Date:  2014-02-26       Impact factor: 2.965

9.  Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.

Authors:  Ping Li; Yue Tan; Li-Xia Zhu; Li-Na Zhou; Ping Zeng; Qin Liu; Min-Bin Chen; Ye Tian
Journal:  Oncotarget       Date:  2017-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.